T1	Participants 311 366	patients with clinical stage I/II Hodgkin lymphoma (HL)
T2	Participants 75 96	I/II Hodgkin lymphoma
T3	Participants 666 735	patients attaining a negative early PET scan after two cycles of ABVD
T4	Participants 1301 1315	1,137 patients
